Supreme Court Delays Ruling on Abortion Pill Access in Food and Drug Administration v. WEB
Delayed Ruling
On April 19, 2023, the Supreme Court issued a brief order delaying its ruling on access to the abortion pill in the case Food and Drug Administration v. WEB. The delay comes after a district judge in Amarillo, Texas, appointed by former President Trump, ruled in favor of anti-abortion doctors who were suing the FDA.The Case
The case centers on mifepristone, a drug used in a two-drug protocol to end pregnancies in their early stages. The district judge's ruling was considered a major victory for anti-abortion advocates and sent shock waves across the medical and legal worlds.Side Effects
Mifepristone has been approved by the FDA since 2000 and is considered safe and effective. The most commonly reported side effects are cramping and prolonged heavy bleeding. Some people also experience nausea, fever, and chills.The Supreme Court's delay in ruling on the case has created uncertainty for women seeking abortion care and for doctors who prescribe mifepristone. It remains to be seen how the Court will ultimately rule, but the delay is a significant setback for access to abortion care in the United States.
Komentar